Moderna’s mRNA COVID-19 vaccine (mRNA-1273) fast-tracked by FDA
Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced on May 12, that
Read more
RNA
Moderna and Lonza partner up to manufacture COVID-19 vaccine
Moderna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more
Intermediate analysis of Moderna’s Phase I Zika Vaccine (mRNA-1893)
The first intermediate analysis of the Phase I Zika vaccine candidate sample (mRNA-1893) reveals that the dosage levels of 10
Read more
Skin cancer drug trial boosts CK Life Sciences stock by 240%
CK Life Sciences stock jumps 240% as skin cancer drug trial looks promising. Seviprotimut-L could serve as a significant innovation in the vaccine-based treatment of melanoma.
Read more